Because of the stagnant nature in which the stem cell stocks have been performing the last few months, I've decide to adjust my posting intervals to every two weeks. Once again, select names have been performing steadily, but overall nothing special has occurred in the sector.
Top Stem Cell Stock Performer(s) the Last Two Weeks:
- Advanced Cell Technology (ACT.OB) = Up 51%; There's been no real news, but the stock's been on a technical tear. If it breaks out of the 25-30 cent range, it could double.
Worst Stem Cell Stock Performer(s) the Last Two Weeks:
-ThermoGenesis Corp. (KOOL) = Down -15%; After a 50% spike up a few weeks ago, this stock has come crashing back down to earth. It looks like it needs news to move higher.
Stem Cell Stocks Current Price and % Up or Down 6/15/09 - 6/26/09
Market Cap Over 50 Million
Ariad Pharmaceuticals (ARIA) = Cur Price: $1.66; Down -11%
Aastrom Biosciences (ASTM) = Cur Price: $0.40; Up 14%
BioTime, Inc. (BTIM) = Cur Price: $2.40; Down -9%
Celgene Corp (CELG) = Cur Price: $48.03; Up 11%
Cytori Therapeutics (CYTX) = Cur Price: $3.95; Down -2%
Geron Corp (GERN) = Cur Price: $6.95; Up 1%
ThermoGenesis (KOOL) = Cur Price: $0.62; Down-15%
Osiris Therapeutics (OSIR) = Cur Price: $13.25; Down -5%
StemCell Inc. (STEM) = Cur Price: $1.80; Up 8%
Market Cap Under 50 Million
Advanced Cell Technology (ACTC.OB) = Cur Price: $0.252; Up 51%
Athersys Inc. (ATHX) = Cur Price: $0.83; Down -12%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.07; Down -6%
Bioheart Inc. (BHRT) = Cur Price: $0.85; Up 1%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0038; Down -7%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.15; Down -4%
Neuralstem (CUR) = Cur Price: $1.20; Up 10%
International Stem Cell (ISCO.OB) = Cur Price: $0.80; Down-13%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0105; Down -19%
Pluristem Therapeutics (PSTI) = Cur Price: $1.27; Down -5%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.05; Down -9%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.036; Down -5%
Catalyst(s):
Still, nothing has changed from the last few months.
- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves.
Stem Cell Stocks 6/14/09: The Week That Was
It appears that the moved in the stem cell stocks two weeks ago was nothing more the a blip on the radar. Last week was much of the same mixed bag action we've seen the past 3 or 4 months. I believe these stocks are still waiting for a catalyst to break through.
Top Stem Cell Stock Performer(s) for Last Week:
None
Worst Stem Cell Stock Performer(s) for Last Week:
-Stem Cell Innovations (SCLL.OB) = Down -21%; This stock has been getting killed since its brief run in February. There has been no news, just continued downward pressure.
Stem Cell Stocks Current Price and % Up or Down 6/8/09 - 6/12/09
Market Cap Over 50 Million
Ariad Pharmaceuticals (ARIA) = Cur Price: $1.86; Up 12%
Aastrom Biosciences (ASTM) = Cur Price: $0.351; Down -3%
BioTime, Inc. (BTIM) = Cur Price: $2.63; Down -6%
Celgene Corp (CELG) = Cur Price: $43.23; Down -3%
Cytori Therapeutics (CYTX) = Cur Price: $4.04; Down -8%
Geron Corp (GERN) = Cur Price: $6.85; Unchanged
ThermoGenesis (KOOL) = Cur Price: $0.73; Unchanged
Osiris Therapeutics (OSIR) = Cur Price: $13.91; Down -1%
StemCell Inc. (STEM) = Cur Price: $1.66; Down -5%
Market Cap Under 50 Million
Advanced Cell Technology (ACTC.OB) = Cur Price: $0.167; Up 8%
Athersys Inc. (ATHX) = Cur Price: $0.94; Up 5%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.0748; Up 3%
Bioheart Inc. (BHRT) = Cur Price: $0.84; Up 6%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0041; Up 3%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.20; Down -4%
Neuralstem (CUR) = Cur Price: $1.09; Down -8%
International Stem Cell (ISCO.OB) = Cur Price: $0.92; Up 1%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0129; Down -13%
Pluristem Therapeutics (PSTI) = Cur Price: $1.33; Up 5%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.055; Up 12%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.038; Down -21%
Catalyst(s):
Nothing has changed from the last few months.
- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves.
Top Stem Cell Stock Performer(s) for Last Week:
None
Worst Stem Cell Stock Performer(s) for Last Week:
-Stem Cell Innovations (SCLL.OB) = Down -21%; This stock has been getting killed since its brief run in February. There has been no news, just continued downward pressure.
Stem Cell Stocks Current Price and % Up or Down 6/8/09 - 6/12/09
Market Cap Over 50 Million
Ariad Pharmaceuticals (ARIA) = Cur Price: $1.86; Up 12%
Aastrom Biosciences (ASTM) = Cur Price: $0.351; Down -3%
BioTime, Inc. (BTIM) = Cur Price: $2.63; Down -6%
Celgene Corp (CELG) = Cur Price: $43.23; Down -3%
Cytori Therapeutics (CYTX) = Cur Price: $4.04; Down -8%
Geron Corp (GERN) = Cur Price: $6.85; Unchanged
ThermoGenesis (KOOL) = Cur Price: $0.73; Unchanged
Osiris Therapeutics (OSIR) = Cur Price: $13.91; Down -1%
StemCell Inc. (STEM) = Cur Price: $1.66; Down -5%
Market Cap Under 50 Million
Advanced Cell Technology (ACTC.OB) = Cur Price: $0.167; Up 8%
Athersys Inc. (ATHX) = Cur Price: $0.94; Up 5%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.0748; Up 3%
Bioheart Inc. (BHRT) = Cur Price: $0.84; Up 6%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.0041; Up 3%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.20; Down -4%
Neuralstem (CUR) = Cur Price: $1.09; Down -8%
International Stem Cell (ISCO.OB) = Cur Price: $0.92; Up 1%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0129; Down -13%
Pluristem Therapeutics (PSTI) = Cur Price: $1.33; Up 5%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.055; Up 12%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.038; Down -21%
Catalyst(s):
Nothing has changed from the last few months.
- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves.
Stem Cell Stocks 6/07/09: The Week That Was
Mark this week's post as the start of a possible stem cell stock turnaround. For the first time since January, every larger cap stem cell stock that we follow finished the week in positive territory. The sector has not done much in last three months with the exception of moves the last month by Geron and Cytori Therapeutics. There has been no notable catalyst that has caused this shift in activity. As a result, a follow up week will be big in determining if the stem cell stocks have new life.
Top Stem Cell Stock Performer(s) for Last Week:
- ThermoGenesis Corp (KOOL) = Up 38% for the week; Volume jumped significantly in KOOL during later part of the week. Either news is coming or institutions have begun to buy
Worst Stem Cell Stock Performer(s) for Last Week:
-Stem Cell Therapy Intl (SCII.OB) = Down -18; This stock has been in free fall from $0.12/share since April. Based on the chart, I wouldn't consider buying this until it hits $0.02 a share
Stem Cell Stocks Current Price and % Up or Down 6/1/09 - 6/5/09
Market Cap Over 50 Million
Ariad Pharmaceuticals (ARIA) = Cur Price: $1.66; Up 11%
Aastrom Biosciences (ASTM) = Cur Price: $0.361; Up 8%
BioTime, Inc. (BTIM) = Cur Price: $2.80; Up 10%
Celgene Corp (CELG) = Cur Price: $44.35; Up 5%
Cytori Therapeutics (CYTX) = Cur Price: $4.37; Up 15%
Geron Corp (GERN) = Cur Price: $6.83; Up 5%
ThermoGenesis (KOOL) = Cur Price: $0.73; Up 38%
Osiris Therapeutics (OSIR) = Cur Price: $14.11; Up 12%
StemCell Inc. (STEM) = Cur Price: $1.75; Up 7%
Market Cap Under 50 Million
Advanced Cell Technology (ACTC.OB) = Cur Price: $0.155; Up 5%
Athersys Inc. (ATHX) = Cur Price: $0.899; Up 7%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.0725; Up 4%
Bioheart Inc. (BHRT) = Cur Price: $0.79; Down -6%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.004; Down -2%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.25; Unchanged
Neuralstem (CUR) = Cur Price: $1.19; Up 13%
International Stem Cell (ISCO.OB) = Cur Price: $0.91; Down -9%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0149; Down -10%
Pluristem Therapeutics (PSTI) = Cur Price: $1.27; Up 2%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.049; Down -18%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.048; Unchanged
Catalyst(s):
Nothing has changed from the last few months.
- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves
Top Stem Cell Stock Performer(s) for Last Week:
- ThermoGenesis Corp (KOOL) = Up 38% for the week; Volume jumped significantly in KOOL during later part of the week. Either news is coming or institutions have begun to buy
Worst Stem Cell Stock Performer(s) for Last Week:
-Stem Cell Therapy Intl (SCII.OB) = Down -18; This stock has been in free fall from $0.12/share since April. Based on the chart, I wouldn't consider buying this until it hits $0.02 a share
Stem Cell Stocks Current Price and % Up or Down 6/1/09 - 6/5/09
Market Cap Over 50 Million
Ariad Pharmaceuticals (ARIA) = Cur Price: $1.66; Up 11%
Aastrom Biosciences (ASTM) = Cur Price: $0.361; Up 8%
BioTime, Inc. (BTIM) = Cur Price: $2.80; Up 10%
Celgene Corp (CELG) = Cur Price: $44.35; Up 5%
Cytori Therapeutics (CYTX) = Cur Price: $4.37; Up 15%
Geron Corp (GERN) = Cur Price: $6.83; Up 5%
ThermoGenesis (KOOL) = Cur Price: $0.73; Up 38%
Osiris Therapeutics (OSIR) = Cur Price: $14.11; Up 12%
StemCell Inc. (STEM) = Cur Price: $1.75; Up 7%
Market Cap Under 50 Million
Advanced Cell Technology (ACTC.OB) = Cur Price: $0.155; Up 5%
Athersys Inc. (ATHX) = Cur Price: $0.899; Up 7%
Brainstorm Cell Therapeutics (BCLI.OB) = Cur Price: $0.0725; Up 4%
Bioheart Inc. (BHRT) = Cur Price: $0.79; Down -6%
Cord Blood America Inc. (CBAI.OB) = Cur Price: $0.004; Down -2%
Cyro-Cell Intl (CCEL.OB) = Cur Price: $1.25; Unchanged
Neuralstem (CUR) = Cur Price: $1.19; Up 13%
International Stem Cell (ISCO.OB) = Cur Price: $0.91; Down -9%
MultiCell Technologies (MCET.OB) = Cur Price: $0.0149; Down -10%
Pluristem Therapeutics (PSTI) = Cur Price: $1.27; Up 2%
Stem Cell Therapy Intl (SCII.OB) = Cur Price: $0.049; Down -18%
Stem Cell Innovations (SCLL.PK) = Cur Price: $0.048; Unchanged
Catalyst(s):
Nothing has changed from the last few months.
- M&A (mergers and acquisitions) activity will be key. I can't believe that there hasn't been any activity yet, but I think it will happen as the economy improves
Subscribe to:
Posts (Atom)
Posts
